Open-angle Glaucoma: Clinical Trials

8 trials for Open-angle Glaucoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 8 Phase 1, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 18Completed 8
Phase 26Completed 6

Follow Open-angle Glaucoma: new trials by email Literature Review of Open-angle Glaucoma trials Research Report on Open-angle Glaucoma

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of PER-001 in Participants With Open-Angle Glaucoma
PER-001 Intravitreal Implant - Low Dose, PER-001 Intravitreal Implant - High Dose, PER-001 Intravitreal Implant - Sham - Open-angle Glaucoma
Phase 1 / Phase 2CompletedPerfuse Therapeutics, Inc.332023-05-252026-06-05
Safety and Tolerability of a Prostaglandin Ocular Implant for Treatment of Open Angle Glaucoma
PA5108 - Open-angle Glaucoma
Phase 1CompletedPolyActiva Pty Ltd82018-07-242020-09-16
Single-dose Study of ANX007 in Participants With Primary Open-angle Glaucoma
ANX007 - Open-angle Glaucoma
Phase 1CompletedAnnexon, Inc.92018-03-232020-08-20
A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension
Fixed Combination, Bimatoprost, Timolol - Open-Angle Glaucoma, Ocular Hypertension
Phase 1 / Phase 2CompletedForSight Vision5, Inc.552016-04-302019-02-25
A Three Part Study of MGV354 in Ocular Hypertension or Glaucoma
MGV354 ophthalmic suspension, MGV354 placebo - Ocular Hypertension, Open-Angle Glaucoma
Phase 1 / Phase 2CompletedAlcon Research1912016-03-022018-07-02
Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension
DE-112, DE-112 Vehicle Solution, Timolol Maleate Solution - Open-angle Glaucoma, Ocular Hypertension
Phase 1 / Phase 2CompletedSanten Inc.1472011-01-012012-12-17
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
bimatoprost 20 µg generation 2, bimatoprost 15 µg generation 2, bimatoprost 10 µg generation 2 - Open-Angle Glaucoma, Ocular Hypertension
Phase 1 / Phase 2CompletedAllergan1092010-09-232020-03-30
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension
DE-104 medium concentration, DE-104 high concentration, Placebo - Open-Angle Glaucoma, Ocular Hypertension
Phase 1 / Phase 2CompletedSanten Inc.492009-03-012011-11-03

Narrower conditions

Glaucoma, Open-Angle (8)  ·  Ocular Hypertension (5)  ·  Glaucoma (1)

Broader conditions

Eye Diseases (8)  ·  Glaucoma (7)  ·  Ocular Hypertension (3)

Interventions

Bimatoprost (2)  ·  Latanoprost (1)  ·  Timolol (1)

Sponsors

Santen Inc. (2)  ·  Alcon Research (1)  ·  Allergan (1)  ·  Annexon, Inc. (1)  ·  ForSight Vision5, Inc. (1)  ·  Perfuse Therapeutics, Inc. (1)  ·  PolyActiva Pty Ltd (1)

Countries

United States (5)  ·  Australia (2)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  Germany (1)  ·  Israel (1)  ·  Panama (1)  ·  Philippines (1)  ·  Singapore (1)  ·  Spain (1)

Top investigators

Eric Humphriss (1)  ·  Michelle Chen, PhD (1)  ·  Nathan Kerr (1)  ·  Phillip Lai, MD (1)

Results publications

PMID 29802818, PMID 35643967